FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Why alarm is easing over a rise in pancreatic cancer among the young

2.

Rural residents continue to have higher odds of skin cancer, study finds

3.

As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.

4.

The Kansas Cancer Center awarded two Indian American doctors professorships.

5.

Researchers explore e-bikes for cancer recovery


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot